Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity

Neuropsychopharmacology

Volumn 36, Issue 9, 2011, Pages 1940-1947

  Nikolova, Yuliya S ^a   Ferrell, Robert E ^b   Manuck, Stephen B ^c   Hariri, Ahmad R ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

dopamine; fMRI; genetic profile; reward; ventral striatum

Indexed keywords

DOPAMINE;

ADULT; ALLELE; ARTICLE; BOLD SIGNAL; BRAIN FUNCTION; BRAIN LEVEL; CAUCASIAN; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MALE; MULTILOCUS SEQUENCE TYPING; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; BASAL GANGLIA; COHORT STUDIES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SIGNAL TRANSDUCTION;

EID: 79960309639     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.82     Document Type: Article

References (57)

1. Arinami T, Gao M, Hamaguchi H, Toru M (1997). A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6: 577-582. (Pubitemid 27142107)
2. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH (1995). Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65: 1157-1165.
3. Bakker PR, van Harten PN, van Os J (2008). Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and Mn SOD genes: a meta-analysis ofpharmacogenetic interactions. Mol Psychiatry 13: 544-556. (Pubitemid 351556033)
4. Beaulieu JM, Gainetdinov RR (2011). The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63: 182-217.
5. Besson C, Louilot A (1995). Asymmetrical involvement of mesolimbic dopaminergic neurons in affective perception. Neuroscience 68: 963-968.
6. Buckholtz JW, Sust S, Tan HY, Mattay VS, Straub RE, Meyer-Lindenberg A et al (2007). f MRI evidence for functional epistasis between COMT and RGS4. Mol Psychiatry 12: 893-895, 885. (Pubitemid 47482697)
7. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R et al (2010a). Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci 13: 419-421.
8. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al (2010b). Dopaminergic network differences in human impulsivity. Science 329: 532.
9. Carre JM, Fisher PM, Manuck SB, Hariri AR. Interaction between trait anxiety and trait anger predict amygdala reactivity to angry facial expressions in men but not women. Soc Cogn Affect Neurosci (in press).
10. Caspi A, Moffitt TE (2006). Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7: 583-590. (Pubitemid 43995433)
11. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on m RNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75: 807-821. (Pubitemid 39390488)
12. Cook R, Weisber S (1982). Residuals and Influence in Regression. Chapman & Hall: New York.
13. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC et al (2002). Parameters for reliable results in genetic association studies in common disease. Nat Genet 30: 149-150.
14. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K et al (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270. (Pubitemid 46364262)
15. Derringer J, Krueger RF, Dick DM, Saccone S, Grucza RA, Agrawal A et al (2010). Predicting sensation seeking from dopamine genes. A candidate-system approach. Psychol Sci 21: 1282-1290.
16. Dillon DG, Bogdan R, Fagerness J, Holmes AJ, Perlis RH, Pizzagalli DA (2010). Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum Brain Mapp 31: 210-221.
17. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF (2009). Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106: 617-622.
18. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922. (Pubitemid 32538317)
19. First MB, Spitzer RL, Gibbon M, Williams JBM (1996). Structured Clinical Interviewfor DSM-IVAxis IDisorders, Research Version, Non-Patient Edition. New York State Psychiatric Institute, Biometrics Research Department: New York.
20. Fisher PM, Meltzer CC, Price JC, Coleman RL, Ziolko SK, Becker C et al (2009). Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb Cortex 19: 2499-2507.
21. Fisher PM, Meltzer CC, Ziolko SK, Price JC, Moses-Kolko EL, Berga SL et al (2006). Capacity for 5-HT1A-mediated auto-regulation predicts amygdala reactivity. Nat Neurosci 9: 1362-1363. (Pubitemid 44646205)
22. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009). Genetic variation in components of dopamine neuro-transmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14: 60-70.
23. Gan JO, Walton ME, Phillips PE (2010). Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine. Nat Neurosci 13: 25-27.
24. Gianaros PJ, Manuck SB, Sheu LK, Kuan DC, Votruba-Drzal E, Craig AE et al (2010). Parental education predicts corticostriatal functionality in adulthood. Cereb Cortex 21: 896-910.
25. Hariri AR (2009). The neurobiology of individual differences in complex behavioral traits. Annu Rev Neurosci 32: 225-247.
26. Hariri AR, Brown SM, Williamson DE, Flory JD, de Wit H, Manuck SB (2006). Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci 26: 13213-13217. (Pubitemid 46011631)
27. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F et al (2009). Divergent effects ofgenetic variation in endocannabinoid signaling on human threat-and reward-related brain function. Biol Psychiatry 66: 9-16.
28. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400-403. (Pubitemid 34790769)
29. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22: 133-139. (Pubitemid 30016015)
30. Hyde LW, Gorka A, Manuck SB, Hariri AR (2010). Perceived social support moderates the link between threat-related amygdala reactivity and trait anxiety. Neuropsychologia 49: 651-656.
31. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S et al (2009). A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66: 966-975.
32. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M (2009). Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci 29: 3695-3704.
33. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P et al (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4: 290-296. (Pubitemid 29292183)
34. Kienast T, Hariri AR, Schlagenhauf F, Wrase J, Sterzer P, Buchholz HG et al (2008). Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nat Neurosci 11: 1381-1382.
35. Kwon JS, Kim E, Kang DH, Choi JS, Yu KS, Jang IJ et al (2008). Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole. Eur Neuropsycho-pharmacol 18: 897-907.
36. Merali Z, Mc Intosh J, Anisman H (2004). Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsycho pharmacology 29: 1409-1418. (Pubitemid 38982232)
37. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, A RH, Pezawas L, Blasi G et al (2006). Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 103: 6269-6274.
38. Nicodemus KK, Callicott JH, Higier RG, Luna A, Nixon DC, Lipska BK et al (2010). Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. Hum Genet 127: 441-452.
39. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991). Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48: 648-654.
40. Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC (1997). D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 74: 162-166. (Pubitemid 27187645)
41. Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS et al (2008). Evidence ofbiologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 13: 709-716. (Pubitemid 351861533)
42. Plomin R, Haworth CM, Davis OS (2009). Common disorders are quantitative traits. Nat Rev Genet 10: 872-878.
43. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK et al (1998). The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3: 256-260. (Pubitemid 28266335)
44. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH et al (2009). Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4: e6501.
45. Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T et al (2008). Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage 42: 1631-1638.
46. Sesack SR, Grace AA (2010). Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology 35: 27-47.
47. Seshadri S, De Stefano AL, Au R, Massaro JM, Beiser AS, Kelly-Hayes M et al (2007). Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet 8(Suppl 1): S15.
48. Spreckelmeyer KN, Krach S, Kohls G, Rademacher L, Irmak A, Konrad K et al (2009). Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women. Soc Cogn Affect Neurosci 4: 158-165.
49. Stice E, Spoor S, Bohon C, Small DM (2008). Relation between obesity and blunted striatal response to food is moderated by Taq IA A1 allele. Science 322: 449-452.
50. Sullivan RM, Dufresne MM (2006). Mesocortical dopamine and HPA axis regulation: role of laterality and early environment. Brain Res 1076: 49-59. (Pubitemid 43376022)
51. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S (2004). Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat Neurosci 7: 887-893. (Pubitemid 38989513)
52. van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J (2009). Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50: 45-52.
53. Van Ness SH, Owens MJ, Kilts CD (2005). The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 6: 55.
54. Viviani R (2010). Unbiased ROI selection in neuroimaging studies ofindividual differences. Neuroimage 50: 184-189.
55. Wang E, Ding YC, Flodman P, Kidd JR, Kidd KK, Grady DL et al (2004). The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet 74: 931-944. (Pubitemid 38568966)
56. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B et al (2007). Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 104: 8125-8130. (Pubitemid 47185886)
57. Young EJ, Williams CL (2010). Valence dependent asymmetric release of norepinephrine in the basolateral amygdala. Behav Neurosci 124: 633-644.